Neel Shah, MD, MMP shares his thoughts on the ARRIVE Trial. Dr. Shah is recognized as an innovative leader in maternal-infant health and a well-respected expert on effective methods for reducing the cesarean rate in the U.S.
Henci Goer examines the just-released ARRIVE Trial to determine if there is new information compared to the study abstract that raises more questions or answers the old ones? What should birth professionals understand and share with consumers about the evidence to induce at 39 weeks?
Author and evidence-based maternity care expert Henci Goer, a frequent Science & Sensibility contributor, examines the abstract of the ARRIVE Trial (the only published material from the study available at this time) and shares with S&S readers her careful examination of the study's conclusions.
Today on Science & Sensibility, contributor Henci Goer takes a look at a systematic review released in spring that examined the impact of elective inductions on the cesarean rate. Sound analysis or a house of cards? Looking closer at the studies reviewed provides insight into how the
Today on Evidence Based Birth, occasional contributor Rebecca Dekker, Phd, RN, APRN, provides a comprehensive research review – Induction for Going Past your Due Date: What does the Evidence Say? I had an opportunity to preview the article and ask Rebecca some questions about her most recent proje